Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1996 Jul;89(7):389–392. doi: 10.1177/014107689608900709

Alcohol abuse and stage of HIV disease in intravenous drug abusers.

G Lake-Bakaar 1, R Grimson 1
PMCID: PMC1295853  PMID: 8774537

Abstract

Our objective was to identify factors that might correlate with human immunodeficiency virus (HIV) disease stage in intravenous drug abusers (IVDA). Particular attention was given to alcohol abuse. We accordingly explored in a cross-sectional study the relation between stage of HIV disease and age, sex, needle sharing, ethnicity, self-reported history of alcohol consumption and CAGE scores. IVDA from a single municipal hospital were subdivided into three groups according to HIV disease status. Group 1 comprised 42 individuals with AIDS; group 2 comprised 114 who were HIV positive but without AIDS; and group 3 comprised 52 who were HIV negative. Information on alcohol consumption and CAGE responses were obtained by questionnaire and interview. Discriminant analysis indicated that alcohol abuse, assessed either by self-reported consumption or by CAGE scores, was significantly more common in the AIDS group than in either the HIV positive or the HIV negative groups, when controlled for age, sex, and needle sharing status. The relative risk of AIDS was 3.8 times higher in the heavy drinkers than in moderate drinkers. Needle sharing was also more common in the AIDS group than in the HIV positive or HIV negative groups when the other factors were controlled for. AIDS was more common in black than white IVDA, and this increased frequency did not appear related to alcohol consumption since the distribution of heavy drinkers within each category of HIV disease did not differ within the ethnic groups. These data indicate that a history of heavy alcohol consumption is more common in IVDA with AIDS than in IVDA at earlier stages of HIV disease.

Full text

PDF
389

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bagasra O., Kajdacsy-Balla A., Lischner H. W. Effects of alcohol ingestion on in vitro susceptibility of peripheral blood mononuclear cells to infection with HIV and of selected T-cell functions. Alcohol Clin Exp Res. 1989 Oct;13(5):636–643. doi: 10.1111/j.1530-0277.1989.tb00396.x. [DOI] [PubMed] [Google Scholar]
  2. Bowen D. L., Lane H. C., Fauci A. S. Immunopathogenesis of the acquired immunodeficiency syndrome. Ann Intern Med. 1985 Nov;103(5):704–709. doi: 10.7326/0003-4819-103-5-704. [DOI] [PubMed] [Google Scholar]
  3. Bush B., Shaw S., Cleary P., Delbanco T. L., Aronson M. D. Screening for alcohol abuse using the CAGE questionnaire. Am J Med. 1987 Feb;82(2):231–235. doi: 10.1016/0002-9343(87)90061-1. [DOI] [PubMed] [Google Scholar]
  4. De Cock K. M., Niland J. C., Lu H. P., Rahimian A., Edwards V., Shriver K., Govindarajan S., Redeker A. G. Experience with human immunodeficiency virus infection in patients with hepatitis B virus and hepatitis delta virus infections in Los Angeles, 1977-1985. Am J Epidemiol. 1988 Jun;127(6):1250–1260. doi: 10.1093/oxfordjournals.aje.a114917. [DOI] [PubMed] [Google Scholar]
  5. Fauci A. S., Schnittman S. M., Poli G., Koenig S., Pantaleo G. NIH conference. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Ann Intern Med. 1991 Apr 15;114(8):678–693. doi: 10.7326/0003-4819-114-8-678. [DOI] [PubMed] [Google Scholar]
  6. Flavin D. K., Frances R. J. Risk-taking behavior, substance abuse disorders, and the acquired immune deficiency syndrome. Adv Alcohol Subst Abuse. 1987 Spring;6(3):23–32. doi: 10.1300/J251v06n03_03. [DOI] [PubMed] [Google Scholar]
  7. Ho D. D., Pomerantz R. J., Kaplan J. C. Pathogenesis of infection with human immunodeficiency virus. N Engl J Med. 1987 Jul 30;317(5):278–286. doi: 10.1056/NEJM198707303170505. [DOI] [PubMed] [Google Scholar]
  8. Joseph S. C. Current and future trends in AIDS in New York City. Adv Alcohol Subst Abuse. 1987;7(2):159–174. doi: 10.1300/j251v07n02_13. [DOI] [PubMed] [Google Scholar]
  9. Kaslow R. A., Blackwelder W. C., Ostrow D. G., Yerg D., Palenicek J., Coulson A. H., Valdiserri R. O. No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1-positive individuals. A report from the Multicenter AIDS Cohort Study. JAMA. 1989 Jun 16;261(23):3424–3429. [PubMed] [Google Scholar]
  10. Lindan C. P., Hearst N., Singleton J. A., Trachtenberg A. I., Riordan N. M., Tokagawa D. A., Chu G. S. Underreporting of minority AIDS deaths in San Francisco Bay area, 1985-86. Public Health Rep. 1990 Jul-Aug;105(4):400–404. [PMC free article] [PubMed] [Google Scholar]
  11. MacGregor R. R. Alcohol and drugs as co-factors for AIDS. Adv Alcohol Subst Abuse. 1987;7(2):47–71. doi: 10.1300/j251v07n02_06. [DOI] [PubMed] [Google Scholar]
  12. MacGregor R. R. Alcohol and immune defense. JAMA. 1986 Sep 19;256(11):1474–1479. [PubMed] [Google Scholar]
  13. Novick D. M., Des Jarlais D. C., Kreek M. J., Spira T. J., Friedman S. R., Gelb A. M., Stenger R. J., Schable C. A., Kalyanaraman V. S. Specificity of antibody tests for human immunodeficiency virus in alcohol and parenteral drug abusers with chronic liver disease. Alcohol Clin Exp Res. 1988 Oct;12(5):687–690. doi: 10.1111/j.1530-0277.1988.tb00266.x. [DOI] [PubMed] [Google Scholar]
  14. Schoenbaum E. E., Hartel D., Selwyn P. A., Klein R. S., Davenny K., Rogers M., Feiner C., Friedland G. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med. 1989 Sep 28;321(13):874–879. doi: 10.1056/NEJM198909283211306. [DOI] [PubMed] [Google Scholar]
  15. Selik R. M., Castro K. G., Pappaioanou M. Racial/ethnic differences in the risk of AIDS in the United States. Am J Public Health. 1988 Dec;78(12):1539–1545. doi: 10.2105/ajph.78.12.1539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Smith W. I., Jr, Van Thiel D. H., Whiteside T., Janoson B., Magovern J., Puet T., Rabin B. S. Altered immunity in male patients with alcoholic liver disease: evidence for defective immune regulation. Alcohol Clin Exp Res. 1980 Apr;4(2):199–206. doi: 10.1111/j.1530-0277.1980.tb05635.x. [DOI] [PubMed] [Google Scholar]
  17. Snyder N., Bessoff J., Dwyer J. M., Conn H. O. Depressed delayed cutaneous hypersensitivity in alcoholic hepatitis. Am J Dig Dis. 1978 Apr;23(4):353–358. doi: 10.1007/BF01072420. [DOI] [PubMed] [Google Scholar]
  18. Watson R. R., Jackson J. C., Hartmann B., Sampliner R., Mobley D., Eskelson C. Cellular immune functions, endorphins, and alcohol consumption in males. Alcohol Clin Exp Res. 1985 May-Jun;9(3):248–254. doi: 10.1111/j.1530-0277.1985.tb05745.x. [DOI] [PubMed] [Google Scholar]
  19. Watson R. R., Jackson J. C., Hartmann B., Sampliner R., Mobley D., Eskelson C. Cellular immune functions, endorphins, and alcohol consumption in males. Alcohol Clin Exp Res. 1985 May-Jun;9(3):248–254. doi: 10.1111/j.1530-0277.1985.tb05745.x. [DOI] [PubMed] [Google Scholar]
  20. Watson R. R., McMurray D. N. The effects of malnutrition on secretory and cellular immune processes. CRC Crit Rev Food Sci Nutr. 1979 Dec;12(2):113–159. doi: 10.1080/10408397909527275. [DOI] [PubMed] [Google Scholar]
  21. Zetterman R. K., Sorrell M. F. Immunologic aspects of alcoholic liver disease. Gastroenterology. 1981 Sep;81(3):616–624. [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES